AU1277092A - Tetrahydrothieno(2,3-c)pyridine derivatives, process for their preparation and their pharmaceutical application - Google Patents

Tetrahydrothieno(2,3-c)pyridine derivatives, process for their preparation and their pharmaceutical application

Info

Publication number
AU1277092A
AU1277092A AU12770/92A AU1277092A AU1277092A AU 1277092 A AU1277092 A AU 1277092A AU 12770/92 A AU12770/92 A AU 12770/92A AU 1277092 A AU1277092 A AU 1277092A AU 1277092 A AU1277092 A AU 1277092A
Authority
AU
Australia
Prior art keywords
tetrahydrothieno
preparation
pyridine derivatives
pharmaceutical application
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12770/92A
Other languages
English (en)
Inventor
Roberto Colle
Giuseppe Giardina
Vittorio Vecchietti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr L Zambeletti SpA
Original Assignee
Dr L Zambeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr L Zambeletti SpA filed Critical Dr L Zambeletti SpA
Publication of AU1277092A publication Critical patent/AU1277092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12770/92A 1991-03-07 1992-02-22 Tetrahydrothieno(2,3-c)pyridine derivatives, process for their preparation and their pharmaceutical application Abandoned AU1277092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919104839A GB9104839D0 (en) 1991-03-07 1991-03-07 Novel compounds
GB9104839 1991-03-07

Publications (1)

Publication Number Publication Date
AU1277092A true AU1277092A (en) 1992-10-06

Family

ID=10691165

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12770/92A Abandoned AU1277092A (en) 1991-03-07 1992-02-22 Tetrahydrothieno(2,3-c)pyridine derivatives, process for their preparation and their pharmaceutical application

Country Status (5)

Country Link
EP (1) EP0575362A1 (fr)
JP (1) JPH06508348A (fr)
AU (1) AU1277092A (fr)
GB (1) GB9104839D0 (fr)
WO (1) WO1992015592A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
CA2081351A1 (fr) * 1990-04-28 1991-10-29 Vittorio Vecchietti 1-(1-oxo-3,4-dihydro-2h-6-naphtyl)acetylpiperidines; methode de preparation et utilisation comme agents therapeutiques
US6090797A (en) * 1998-09-02 2000-07-18 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
AU5154699A (en) * 1998-09-02 2000-03-27 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives
RU2641648C1 (ru) 2009-12-04 2018-01-19 Суновион Фармасьютикалз, Инк. Полициклические соединения и способы их применения
CN116283877A (zh) 2016-07-29 2023-06-23 赛诺维信制药公司 化合物、组合物及其用途
KR20190065246A (ko) 2016-07-29 2019-06-11 선오비온 파마슈티컬스 인코포레이티드 화합물 및 조성물 및 이들의 용도
MX2019009763A (es) 2017-02-16 2019-11-21 Sunovion Pharmaceuticals Inc Metodos para tratar esquizofrenia.
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
WO2019161238A1 (fr) 2018-02-16 2019-08-22 Sunovion Pharmaceuticals Inc. Sels, formes cristallines et procédés de production associés
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
KR20230003503A (ko) 2020-04-14 2023-01-06 선오비온 파마슈티컬스 인코포레이티드 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228331A (en) * 1988-03-16 1991-10-25 Zambeletti Spa L Amine- and amido-containing heterocyclic compounds and pharmaceutical compositions
GB8824400D0 (en) * 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
GB8827479D0 (en) * 1988-11-24 1988-12-29 Zambeletti Spa L Novel compounds

Also Published As

Publication number Publication date
WO1992015592A1 (fr) 1992-09-17
EP0575362A1 (fr) 1993-12-29
GB9104839D0 (en) 1991-04-17
JPH06508348A (ja) 1994-09-22

Similar Documents

Publication Publication Date Title
HUT70411A (en) Antiparasitic avermectin derivatives, process for preparing them and pharmaceutical compositions containing them
IL89347A0 (en) Thieno(3,2-b)pyridines,process for their preparation and pharmaceutical compositions containing them
HUT50824A (en) Process for producing tetrahydrofuro- and thieno/2,3-c/pyridines and pharmaceutical compositions comprising same
AU6675490A (en) Heterocyclic derivatives, their preparation and medicinal products containing them
AU644540B2 (en) Imidazopyridine derivatives and process for preparation thereof
NZ241943A (en) PYRROLO [2,3-b] PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS
AU1003788A (en) Heteroaryl 3-oxo-propanenitrile derivatives and process for their preparation
AU3352693A (en) Pyridone derivatives, their preparation and use as medicines
AU1161292A (en) Azabicydic and azatricydic derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
AU3352593A (en) Pyridine derivatives, their preparation and use as medicines
AU1277092A (en) Tetrahydrothieno(2,3-c)pyridine derivatives, process for their preparation and their pharmaceutical application
AU3635693A (en) 1,4-dialkylpiperazine derivatives, method for obtaining them and pharmaceutical compositions containing them
AU6667290A (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
AU646173B2 (en) 3-deoxy-mannosamine derivatives and process for their preparation
AU3395293A (en) 1,4-dioxino(2,3-b)pyridine derivatives
AU3503093A (en) Novel adenosine derivatives, their preparation methods and pharmaceutical compositions containing same
AU3758089A (en) Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation
AU4926190A (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use
HUP9602054A3 (en) Benzofuro- and benzothieno[3,2-b]pyridine derivatives, pharmaceutical compositions containing them, and process for the preparation thereof
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU8917891A (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
AU631261B2 (en) Novel pyridine derivatives, pharmaceutical compositions containing them and process for preparing same
AU635080B2 (en) 4-amidino chroman and 4-amidino pyrano(3,2-c)pyridine derivatives, a process for their preparation and pharmaceutical compositions containing them
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
EP0624567A3 (fr) Dérivés de 3-fluorophénol, procédé de leur préparation et leur utilisation.